Literature DB >> 25798245

Mechanism underlying renal failure caused by pathogenic Candida albicans infection.

Shin Jae-Chen1, Jeon Young-Joo2, Park Seon-Min1, Seo Kang Seok3, Shim Jung-Hyun4, Chae Jung-Il2.   

Abstract

Candida albicans (C. albicans) is an opportunistic fungal pathogen that commonly causes nosocomial infections. Systemic candidiasis is encountered with increasing frequency in immunocompromised hosts, leading to renal failure that results in severe morbidity and mortality. The present study investigated the mechanisms underlying kidney susceptibility following infection with several C. albicans strains, such as B311 and SC5314. Fungal growth of the highly virulent SC5314 strain was 103-fold higher compared to the nonpathogenic B311 strain in the kidneys. An intravenous challenge of SC5314 in mice, elevated blood urea nitrogen (BUN) and creatine levels, which resulted in mortality at 8 or 35 days after infection in a dose- and time-dependent manner, whereas all the B311-infected mice had BUN and creatinine levels in the normal range and survived. Whether virulent C. albicans may escape clearance by activating signaling pathways that lead to the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β, was investigated. B311 infections significantly elevated TNF-α and IL-1β mRNA expression in the kidneys, whereas the expression in SC5314-infected mice remained unchanged. Furthermore, B311 infection significantly elevated the plasma levels of TNF-α and IL-1β. These results indicated that the less virulent strains of C. albicans induced pro-inflammatory cytokines in mice. These results determined that an impairment of the protective mechanisms occurred in the kidneys with virulent C. albicans infection.

Entities:  

Keywords:  B311; Candida albicans; SC5314; interleukin-1β; tumor necrosis factor-α

Year:  2014        PMID: 25798245      PMCID: PMC4360833          DOI: 10.3892/br.2014.393

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  22 in total

1.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence.

Authors:  Carol A Kumamoto; Marcelo D Vinces
Journal:  Cell Microbiol       Date:  2005-11       Impact factor: 3.715

3.  Contact lens-induced infection--a new model of Candida albicans keratitis.

Authors:  D M O'Day; W S Head; R D Robinson; R Yang; D Shetlar; M X Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-06       Impact factor: 4.799

4.  Efficacy of antifungal agents in the cornea. I. A comparative study.

Authors:  D M O'Day; R Robinson; W S Head
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

Review 5.  Candida albicans, a major human fungal pathogen.

Authors:  Joon Kim; Peter Sudbery
Journal:  J Microbiol       Date:  2011-05-03       Impact factor: 3.422

6.  Detection of Als proteins on the cell wall of Candida albicans in murine tissues.

Authors:  L L Hoyer; J Clevenger; J E Hecht; E J Ehrhart; F M Poulet
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 7.  Hydrolytic enzymes as virulence factors of Candida albicans.

Authors:  Martin Schaller; Claudia Borelli; Hans C Korting; Bernhard Hube
Journal:  Mycoses       Date:  2005-11       Impact factor: 4.377

8.  Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.

Authors:  R Schindler; S Krautzig; V Lufft; G Lonnemann; A Mahiout; M N Marra; S Shaldon; K M Koch
Journal:  Nephrol Dial Transplant       Date:  1996-01       Impact factor: 5.992

9.  Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.

Authors:  B Descamps-Latscha; A Herbelin; A T Nguyen; P Roux-Lombard; J Zingraff; A Moynot; C Verger; D Dahmane; D de Groote; P Jungers
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

10.  Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis.

Authors:  John R Graybill; Rosie Bocanegra; Laura K Najvar; Steve Hernandez; Robert A Larsen
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more
  7 in total

1.  Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.

Authors:  Murat Kutlu; Selda Sayın-Kutlu; Sema Alp-Çavuş; Şerife Barçın Öztürk; Meltem Taşbakan; Betil Özhak; Onur Kaya; Oya Eren Kutsoylu; Şebnem Şenol-Akar; Özge Turhan; Gülşen Mermut; Bülent Ertuğrul; Hüsnü Pullukcu; Çiğdem Banu Çetin; Vildan Avkan-Oğuz; Nur Yapar; Dilek Yeşim-Metin; Çağrı Ergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-27       Impact factor: 3.267

2.  Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections.

Authors:  David B Sykes; Michelle M Martinelli; Paige Negoro; Shuying Xu; Katrina Maxcy; Kyle Timmer; Adam L Viens; Natalie J Alexander; Johnny Atallah; Brendan D Snarr; Shane R Baistrocchi; Natalie J Atallah; Alex Hopke; Allison Scherer; Ivy Rosales; Daniel Irimia; Donald C Sheppard; Michael K Mansour
Journal:  J Leukoc Biol       Date:  2022-03-31       Impact factor: 6.011

Review 3.  Local antifungal immunity in the kidney in disseminated candidiasis.

Authors:  Chetan V Jawale; Partha S Biswas
Journal:  Curr Opin Microbiol       Date:  2021-05-12       Impact factor: 7.584

4.  IL-23 signaling prevents ferroptosis-driven renal immunopathology during candidiasis.

Authors:  Nicolas Millet; Norma V Solis; Diane Aguilar; Michail S Lionakis; Robert T Wheeler; Nicholas Jendzjowsky; Marc Swidergall
Journal:  Nat Commun       Date:  2022-09-22       Impact factor: 17.694

5.  A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models.

Authors:  Nívea P Sá; Caroline M Lima; Julliana R A Dos Santos; Marliete C Costa; Patrícia P de Barros; Juliana C Junqueira; Jéssica A Vaz; Renata B Oliveira; Beth B Fuchs; Eleftherios Mylonakis; Carlos A Rosa; Daniel A Santos; Susana Johann
Journal:  Future Sci OA       Date:  2018-04-25

6.  Fungicidal Activity of a Safe 1,3,4-Oxadiazole Derivative Against Candida albicans.

Authors:  Daniella Renata Faria; Raquel Cabral Melo; Glaucia Sayuri Arita; Karina Mayumi Sakita; Franciele Abigail Vilugron Rodrigues-Vendramini; Isis Regina Grenier Capoci; Tania Cristina Alexandrino Becker; Patrícia de Souza Bonfim-Mendonça; Maria Sueli Soares Felipe; Terezinha Inez Estivalet Svidzinski; Erika Seki Kioshima
Journal:  Pathogens       Date:  2021-03-07

7.  Enhanced Virulence of Candida albicans by Staphylococcus aureus: Evidence in Clinical Bloodstream Infections and Infected Zebrafish Embryos.

Authors:  Yen-Mu Wu; Po-Yen Huang; Yi-Chuan Cheng; Chih-Hua Lee; Meng-Chieh Hsu; Jang-Jih Lu; Shao-Hung Wang
Journal:  J Fungi (Basel)       Date:  2021-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.